| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107
Uric acid (UA), a product of purine metabolism, is a known scavenger of peroxynitrite (ONOO-), which has been implicated in the pathogenesis of multiple sclerosis and experimental allergic encephalomyelitis (EAE). To determine whether the known therapeutic action of UA in EAE is mediated through its capacity to inactivate ONOO- or some other immunoregulatory phenomenon, the effects of UA on Ag presentation, T cell reactivity, Ab production, and evidence of CNS inflammation were assessed. The inclusion of physiological levels of UA in culture effectively inhibited ONOO--mediated oxidation as well as tyrosine nitration, which has been associated with damage in EAE and multiple sclerosis, but had no inhibitory effect on the T cell-proliferative response to myelin basic protein (MBP) or on APC function. In addition, UA treatment was found to have no notable effect on the development of the immune response to MBP in vivo, as measured by the production of MBP-specific Ab and the induction of MBP-specific T cells. The appearance of cells expressing mRNA for inducible NO synthase in the circulation of MBP-immunized mice was also unaffected by UA treatment. However, in UA-treated animals, the blood-CNS barrier breakdown normally associated with EAE did not occur, and inducible NO synthase-positive cells most often failed to reach CNS tissue. These findings are consistent with the notion that UA is therapeutic in EAE by inactivating ONOO-, or a related molecule, which is produced by activated monocytes and contributes to both enhanced blood-CNS barrier permeability as well as CNS tissue pathology.
This article has been cited by other articles:
|
|
 |
|
  M. J. Fabis, T. W. Phares, R. B. Kean, H. Koprowski, and D. C. Hooper Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity PNAS, October 7, 2008; 105(40): 15511 - 15516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Haussinger and F Schliess Pathogenetic mechanisms of hepatic encephalopathy Gut, August 1, 2008; 57(8): 1156 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Fuhua Peng, Bin Zhang, Xiufeng Zhong, Jin Li, Guihong Xu, Xueqiang Hu, Wei Qiu, and Zhong Pei Serum uric acid levels of patients with multiple sclerosis and other neurological diseases Multiple Sclerosis, March 1, 2008; 14(2): 188 - 196. [Abstract] [PDF]
|
|
|
|
 |
|
 M. K. Kutzing and B. L. Firestein Altered Uric Acid Levels and Disease States J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.E. Gonsette Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis, January 1, 2008; 14(1): 22 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Roy and D. C. Hooper Lethal Silver-Haired Bat Rabies Virus Infection Can Be Prevented by Opening the Blood-Brain Barrier J. Virol., August 1, 2007; 81(15): 7993 - 7998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Phares, M. J. Fabis, C. M. Brimer, R. B. Kean, and D. C. Hooper A Peroxynitrite-Dependent Pathway Is Responsible for Blood-Brain Barrier Permeability Changes during a Central Nervous System Inflammatory Response: TNF-{alpha} Is Neither Necessary nor Sufficient J. Immunol., June 1, 2007; 178(11): 7334 - 7343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Fabis, G. S. Scott, R. B. Kean, H. Koprowski, and D. C. Hooper Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models PNAS, March 27, 2007; 104(13): 5656 - 5661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Roy, T. W. Phares, H. Koprowski, and D. C. Hooper Failure To Open the Blood-Brain Barrier and Deliver Immune Effectors to Central Nervous System Tissues Leads to the Lethal Outcome of Silver-Haired Bat Rabies Virus Infection J. Virol., February 1, 2007; 81(3): 1110 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Phares, R. B. Kean, T. Mikheeva, and D. C. Hooper Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol., June 15, 2006; 176(12): 7666 - 7675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Parathath, S. Parathath, and S. E. Tsirka Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice J. Cell Sci., January 15, 2006; 119(2): 339 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Scott, S. Cuzzocrea, T. Genovese, H. Koprowski, and D. C. Hooper Uric acid protects against secondary damage after spinal cord injury PNAS, March 1, 2005; 102(9): 3483 - 3488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Wilkinson and A. Grove HucR, a Novel Uric Acid-responsive Member of the MarR Family of Transcriptional Regulators from Deinococcus radiodurans J. Biol. Chem., December 3, 2004; 279(49): 51442 - 51450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Scott, R. B. Kean, T. Mikheeva, M. J. Fabis, J. G. Mabley, C. Szabo, and D. C. Hooper The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Scott, S. V. Spitsin, R. B. Kean, T. Mikheeva, H. Koprowski, and D. C. Hooper Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors PNAS, December 10, 2002; 99(25): 16303 - 16308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. PALL NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity FASEB J, September 1, 2002; 16(11): 1407 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Hooper, R. B. Kean, G. S. Scott, S. V. Spitsin, T. Mikheeva, K. Morimoto, M. Bette, A. M. Rohrenbeck, B. Dietzschold, and E. Weihe The Central Nervous System Inflammatory Response to Neurotropic Virus Infection Is Peroxynitrite Dependent J. Immunol., September 15, 2001; 167(6): 3470 - 3477. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
